from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3851/-

LFCtreatmentdescriptionclass of inhibitor

0.122

Amikacinug/mL Amikacintranslation

1.112

Cap5-10ug/mL Capreomycintranslation

2.143

Rox10-50 ug/mL Roxithromycintranslation

-0.091

SM2-5 ug/mL Streptomycintranslation

1.350

Tet5-10 ug/mL Tetracyclinetranslation

0.847

Rif0.2-5ug/mL Rifampicintranscription

-0.006

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.581

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.258

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.039

CPZ10-50 ug/mL Chlorpromazinerespiration

1.087

Clofazimine10-13 ug/mL Clofaziminerespiration

0.071

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.090

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.152

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.153

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.504

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.521

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.891

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.436

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.714

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.301

KCN5-20 ug/mL Potassium cyaniderespiration

-0.738

NaN30.2-2 mM Sodium aziderespiration

-0.773

Nigericin50 uM Nigericinrespiration

0.579

TRC10-150 ug/mL Triclosanrespiration

1.588

TRZ10-25 ug/mL Thioridazinerespiration

-0.270

Valinomycin0.5-10 uM Valinomycinrespiration

-1.009

ZnSO42 mM ZnSO4respiration

-0.254

menadione6-10 ug/mL Menadionerespiration

0.207

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.268

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.975

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.921

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.385

NRP_1Non-replicating persistence stage 1dosRassociated

0.229

Amp0.2mg/mL AmpicillincellWall

0.192

Cephalexin20-100 ug/mL CephalexincellWall

-0.171

Cerulenin0.32-5 ug/mL CerulenincellWall

1.167

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.545

EMB10-20 ug/mL EthambutolcellWall

-0.126

Eta12-40 ug/mL EthionamidecellWall

-0.094

INH0.2-0.4 ug/mL IsoniazidcellWall

0.705

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.125

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.246

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.509

BZA0.12 mg/mL BenzamidearomaticAmides

-0.228

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.118

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.511

H2O24 mM hydrogen peroxideDNAdamaging

-0.387

Levo10 ug/mL LevofloxacinDNAdamaging

-0.402

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.915

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.573

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.103

UVUV-irradiationDNAdamaging

0.031

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.102

Antimycin12.5-50 ug/mL Antimycin A?

-0.861

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.558

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.226

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.085

PA8240.2-2 ug/mL PA-824?

-0.857

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.096

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.825

Verapamil50 uM Verapamil?

-0.588

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.893

methoxatin10-20 ug/mL Methoxatin?